Hims & Hers Health, Inc.
NYSE:HIMS
51.96 (USD) • At close May 9, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Omzet
| 1,476.514 | 872 | 526.916 | 271.878 | 148.757 | 82.558 | 26.679 |
| Kosten van de omzet
| 303.379 | 157.051 | 118.194 | 67.384 | 39.307 | 37.953 | 18.876 |
| Brutowinst
| 1,173.135 | 714.949 | 408.722 | 204.494 | 109.45 | 44.605 | 7.803 |
| Brutowinstmarge
| 0.795 | 0.82 | 0.776 | 0.752 | 0.736 | 0.54 | 0.292 |
| Onderzoek- en ontwikkelingskosten
| 78.819 | 48.227 | 29.237 | 22.379 | 11.238 | 0 | 0 |
| Algemene en administratieve kosten
| 167.767 | 129.883 | 98.192 | 183.634 | 65.605 | 55.863 | 28.002 |
| Verkoop- en marketingkosten
| 678.844 | 446.435 | 272.587 | 135.902 | 58.989 | 63.156 | 55.57 |
| Verkoop-, algemene en administratieve kosten
| 846.611 | 692.73 | 370.779 | 319.536 | 124.594 | 119.019 | 83.572 |
| Overige kosten
| 185.802 | 3.445 | 77.403 | 0.445 | -11.238 | 1.858 | 0 |
| Bedrijfskosten
| 1,111.232 | 744.402 | 477.419 | 319.536 | 124.594 | 119.019 | 83.575 |
| Bedrijfsresultaat
| 61.903 | -29.453 | -68.697 | -115.042 | -15.144 | -74.414 | -75.769 |
| Bedrijfsresultaat ratio
| 0.042 | -0.034 | -0.13 | -0.423 | -0.102 | -0.901 | -2.84 |
| Totaal overige inkomsten en kosten netto
| 9.808 | 7.882 | 2.988 | 4.247 | -2.843 | 2.44 | 0.563 |
| Inkomen voor belasting
| 71.711 | -21.571 | -65.709 | -110.795 | -17.987 | -71.974 | -75.206 |
| Inkomen voor belasting ratio
| 0.049 | -0.025 | -0.125 | -0.408 | -0.121 | -0.872 | -2.819 |
| Belastingkosten
| -54.327 | 1.975 | -0.031 | -3.136 | 0.127 | 0.09 | 0.037 |
| Nettowinst
| 126.038 | -23.546 | -65.678 | -107.659 | -18.114 | -72.064 | -75.243 |
| Nettowinstmarge
| 0.085 | -0.027 | -0.125 | -0.396 | -0.122 | -0.873 | -2.82 |
| WPA (Winst Per Aandeel)
| 0.58 | -0.11 | -0.32 | -0.58 | -0.51 | -2.86 | -1.12 |
| Verwaterde WPA
| 0.53 | -0.11 | -0.32 | -0.58 | -0.51 | -2.86 | -1.12 |
| EBITDA
| 78.991 | -19.938 | -61.223 | -110.967 | -14.087 | -74.154 | 0 |
| EBITDA ratio
| 0.053 | -0.023 | -0.116 | -0.408 | -0.095 | -0.898 | 0 |